Allegheny Health Network

Jefferson and West Penn join just 130 hospitals nationwide to receive the honor from the ACC, and AGH is the only facility in the region with a maximum three-star rating across four surgical categories

Patients at AHN’s Autoimmunity Institute participated in international clinical trial testing of Saphnelo™ (anifrolumab) – the first new biologic agent in more than a decade for the treatment of adult patients with moderate to severe lupus.

With Only 21 Facilities Achieving this Award Nationally, AGH Ranks Among the Most Elite Mitral Valve Programs in the Country